Interactions between the tumor and the blood systemic response of breast cancer patients.
Ontology highlight
ABSTRACT: Although systemic immunity is critical to the process of tumor rejection, cancer research has largely focused on immune cells in the tumor microenvironment. To understand molecular changes in the patient systemic response (SR) to the presence of BC, we profiled RNA in blood and matched tumor from 173 patients. We designed a system (MIxT, Matched Interactions Across Tissues) to systematically explore and link molecular processes expressed in each tissue. MIxT confirmed that processes active in the patient SR are especially relevant to BC immunogenicity. The nature of interactions across tissues (i.e. which biological processes are associated and their patterns of expression) varies highly with tumor subtype. For example, aspects of the immune SR are underexpressed proportionally to the leve
SUBMITTER: Dumeaux V
PROVIDER: S-EPMC5619688 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA